Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Kidney Cancer Lawsuit Filed After Firefighting Foam Exposure

An Idaho man suffering from kidney cancer is pursuing a new lawsuit against the manufacturers of aqueous film-forming foams (AFFF), a type of firefighting foam widely used at military bases and civilian airports for decades. Kidney Cancer and Firefighting Foam … Continue reading

Zantac Lawsuits Move Forward, With Issuance of New Pretrial Orders

The federal multidistrict litigation established for all Zantac lawsuits stemming from recent drug recalls continues to move forward, with the issuance of two new pretrial orders in the U.S. District Court, Southern District of Florida. The first was issued on April … Continue reading

Firefighting Foam Lawsuit Claims PFAS Exposure Caused Lymphoma, Testicular Cancer

A former firefighter from Vermont has filed a new lawsuit alleging his Hodgkin’s lymphoma and testicular cancer were the direct result of exposure to the aqueous film-forming (AFF) firefighting foams  he used on the job. Firefighting Foam Lawsuit Allegations According … Continue reading

Another Heartburn Drug Recalled for Cancer-Causing Impurity

Amneal Pharmaceuticals has announced a nationwide recall of Nizatidine Oral Solution over concerns the medication may contain Nitrosodimethylamine (NDMA) – a probable human carcinogen – above guidelines established by the U.S. Food & Drug Administration (FDA). Nizatidine is indicated to … Continue reading

FDA Priority Review of High-Risk Medical Devices Linked to More Recalls

A new study suggests that Class III medical devices (those considered high-risk) are more likely to be recalled if they come to market via the U.S. Food & Drug Administration’s (FDA) priority review program. FDA Medical Device Approval: Priority Review … Continue reading

Takeda Pharmaceuticals Hit with New Uloric Heart Attack Lawsuit

Takeda Pharmaceuticals is facing yet another lawsuit over Uloric, a gout drug allegedly linked to an increased risk of heart attack and cardiovascular death. Uloric Lawsuit Allegations This new case was filed in the U.S. District Court, Northern District of … Continue reading

Researchers Warn Elmiron Maculopathy Might be Misdiagnosed

Researchers are warning doctors to carefully review medical histories of patients experiencing vision loss and other eye problems, after finding that maculopathy associated with the bladder pain drug Elmiron is easily misdiagnosed. Elmiron Maculopathy Mistaken for Stargardt Disease Their paper, … Continue reading

Zantac Recall News: U.S. Defense Health Agency Issues Ranitidine Warning

The U.S. Defense Health Agency is warning military beneficiaries to stop taking name-brand Zantac and generic ranitidine products, amid concerns that the popular heartburn medications might contain high levels of N-nitrosodimethylamin (NDMA), a probable human carcinogen. Zantac Users Should Switch … Continue reading

Metformin Warning: Study Points to Toxicity with Coronavirus Treatments

Bernstein Liebhard is not currently pursuing lawsuits on this drug, but if you fill out our form, we will let you know if that changes. A new study suggests some potential coronavirus treatments may prove toxic when administered to patients … Continue reading

Coronavirus Could Delay First Atrium C-Qur Hernia Mesh Trial

The federal judge overseeing thousands of lawsuits involving Atrium Medical Corp’s C-Qur hernia mesh products has been asked to postpone an upcoming bellwether trial in light of the continuing coronavirus pandemic. Atrium Wants Hernia Mesh Trial Postponed Until January About 2,000 … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content